Association for Innovation and Biomedical Research on Light and Image
PUBLICATION NAME
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti-Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema.
CEC // Clinical Trials Centre
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti-Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema.
The Macugen Diabetic Retinopathy Study Group
Ophthalmology 2005, 112:1747-57.
2005
